• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

长期生存分析:腹腔镜与开腹肝切除术治疗肝硬化肝细胞癌的比较:单中心经验。

Long-term survival analysis of pure laparoscopic versus open hepatectomy for hepatocellular carcinoma in patients with cirrhosis: a single-center experience.

机构信息

Department of Surgery, The University of Hong Kong, Hong Kong, China.

出版信息

Ann Surg. 2013 Mar;257(3):506-11. doi: 10.1097/SLA.0b013e31827b947a.

DOI:10.1097/SLA.0b013e31827b947a
PMID:23299521
Abstract

INTRODUCTION

Laparoscopic liver resection has been reported as a safe and effective approach to the management of liver cancer. However, studies of long-term outcomes regarding tumor recurrence and patient survival in comparison with the conventional open approach are limited. The aim of this study was to analyze the survival outcome of laparoscopic liver resection versus open liver resection.

PATIENTS AND METHODS

Between October 2002 and September 2009, 32 patients underwent pure laparoscopic liver resection for hepatocellular carcinoma (HCC). Case-matched control patients (n = 64) who received open liver resection for HCC were included for comparison. Patients were matched in terms of cancer stage, tumor size, location of tumor, and magnitude of resection. Immediate operation outcomes, operation morbidity, disease-free survival, and overall survival were compared between groups.

RESULTS

With the laparoscopic group compared with the open resection group, operation time was 232.5 minutes versus 204.5 minutes (P = 0.938), blood loss was 150 mL versus 300 mL (P = 0.001), hospital stay was 4 days versus 7 days (P < 0.0001), postoperative complication was 2 (6.3%) versus 12 (18.8%) (P = 0.184), disease-free survival was 78.5 months versus 29 months (P = 0.086), and overall survival was 92 months versus 71 months (P = 0.142). The disease-free survival for stage II HCC was 22.1 months versus 12.4 months (P = 0.075).

CONCLUSIONS

Laparoscopic liver resection for HCC is associated with less blood loss, shorter hospital stay, and fewer postoperative complications in selected patients with no compromise in survival.

摘要

简介

腹腔镜肝切除术已被报道为一种安全有效的肝癌治疗方法。然而,与传统的开腹手术相比,关于肿瘤复发和患者生存的长期结果的研究有限。本研究旨在分析腹腔镜肝切除术与开腹肝切除术的生存结果。

患者和方法

2002 年 10 月至 2009 年 9 月,32 例肝细胞癌(HCC)患者接受了纯腹腔镜肝切除术。为了进行比较,纳入了 64 例接受开腹肝切除术治疗 HCC 的病例匹配对照患者。根据癌症分期、肿瘤大小、肿瘤位置和切除程度对患者进行匹配。比较两组患者的即刻手术结果、手术发病率、无病生存率和总生存率。

结果

与开腹组相比,腹腔镜组的手术时间为 232.5 分钟对 204.5 分钟(P = 0.938),出血量为 150 毫升对 300 毫升(P = 0.001),住院时间为 4 天对 7 天(P < 0.0001),术后并发症为 2(6.3%)对 12(18.8%)(P = 0.184),无病生存率为 78.5 个月对 29 个月(P = 0.086),总生存率为 92 个月对 71 个月(P = 0.142)。对于 II 期 HCC,无病生存率为 22.1 个月对 12.4 个月(P = 0.075)。

结论

在选择的患者中,腹腔镜肝切除术治疗 HCC 具有出血量少、住院时间短、术后并发症少的优点,而不会影响生存。

相似文献

1
Long-term survival analysis of pure laparoscopic versus open hepatectomy for hepatocellular carcinoma in patients with cirrhosis: a single-center experience.长期生存分析:腹腔镜与开腹肝切除术治疗肝硬化肝细胞癌的比较:单中心经验。
Ann Surg. 2013 Mar;257(3):506-11. doi: 10.1097/SLA.0b013e31827b947a.
2
Outcome of laparoscopic versus open hepatectomy for colorectal liver metastases.腹腔镜与开腹肝切除术治疗结直肠癌肝转移的疗效
ANZ J Surg. 2013 Nov;83(11):847-52. doi: 10.1111/j.1445-2197.2012.06270.x. Epub 2012 Oct 4.
3
Laparoscopic liver resection for hepatocellular carcinoma in cirrhosis: long-term outcomes.腹腔镜肝切除术治疗肝硬化肝细胞癌:长期结果。
Dig Surg. 2011;28(2):134-40. doi: 10.1159/000323824. Epub 2011 Apr 29.
4
Long-term and perioperative outcomes of laparoscopic versus open liver resection for hepatocellular carcinoma with propensity score matching: a multi-institutional Japanese study.倾向评分匹配下腹腔镜与开腹肝切除术治疗肝细胞癌的长期及围手术期结局:一项多机构日本研究
J Hepatobiliary Pancreat Sci. 2015 Oct;22(10):721-7. doi: 10.1002/jhbp.276. Epub 2015 Jul 1.
5
Laparoscopic Versus Open Hepatic Resection for Solitary Hepatocellular Carcinoma Less Than 5 cm in Cirrhotic Patients: A Randomized Controlled Study.腹腔镜与开腹肝切除术治疗肝硬化患者直径小于5厘米的孤立性肝细胞癌:一项随机对照研究
J Laparoendosc Adv Surg Tech A. 2018 Mar;28(3):302-310. doi: 10.1089/lap.2017.0518. Epub 2017 Nov 27.
6
Pure Laparoscopic Hepatectomy Versus Open Hepatectomy for Hepatocellular Carcinoma in 110 Patients With Liver Cirrhosis: A Propensity Analysis at a Single Center.110例肝硬化肝细胞癌患者行单纯腹腔镜肝切除术与开腹肝切除术的倾向分析:单中心研究
Ann Surg. 2016 Oct;264(4):612-20. doi: 10.1097/SLA.0000000000001848.
7
Propensity score analysis of outcomes following laparoscopic or open liver resection for hepatocellular carcinoma.腹腔镜或开腹肝切除术治疗肝细胞癌的结果的倾向评分分析。
Br J Surg. 2016 Jun;103(7):871-80. doi: 10.1002/bjs.10137. Epub 2016 Mar 31.
8
Laparoscopic liver resection for hepatocellular carcinoma: ten-year experience in a single center.腹腔镜下肝癌切除术:单中心十年经验
Arch Surg. 2009 Feb;144(2):143-7; discussion 148. doi: 10.1001/archsurg.2008.536.
9
Pure laparoscopic hepatectomy with augmented reality-assisted indocyanine green fluorescence versus open hepatectomy for hepatocellular carcinoma with liver cirrhosis: A propensity analysis at a single center.纯腹腔镜肝切除术联合增强现实辅助吲哚菁绿荧光与开腹肝切除术治疗肝硬化肝细胞癌:单中心倾向分析
Asian J Endosc Surg. 2018 May;11(2):104-111. doi: 10.1111/ases.12492. Epub 2018 May 10.
10
Case-matched analysis of totally laparoscopic versus open liver resection for HCC: short and middle term results.肝癌全腹腔镜与开腹肝切除术的病例匹配分析:短期和中期结果。
J Surg Oncol. 2010 Jul 1;102(1):82-6. doi: 10.1002/jso.21541.

引用本文的文献

1
Effectiveness of Minimally Invasive Hepatectomy in Patients with Early or Intermediate-Stage Hepatocellular Carcinoma: A Multi-Institutional Cohort Study in an Asian Population.微创肝切除术治疗早期或中期肝细胞癌患者的疗效:一项亚洲人群多机构队列研究
J Hepatocell Carcinoma. 2025 May 7;12:879-890. doi: 10.2147/JHC.S485171. eCollection 2025.
2
Immunotherapy and liver cancer research trends and the 100 most cited articles: A bibliometric analysis.免疫疗法和肝癌研究趋势及 100 篇高被引文章:文献计量分析。
Technol Health Care. 2024;32(6):5141-5155. doi: 10.3233/THC-241111.
3
Efficacy of sequential TACE on primary hepatocellular carcinoma with microvascular invasion after radical resection: a systematic review and meta-analysis.
序贯 TACE 治疗原发性肝癌伴微血管侵犯根治性切除术后的疗效:系统评价和荟萃分析。
World J Surg Oncol. 2023 Sep 5;21(1):277. doi: 10.1186/s12957-023-03160-0.
4
Effect of PIVKA-II and AFP secretion status on early recurrence of hepatocellular carcinoma after open and laparoscopic surgery.肝切除术后甲胎蛋白异质体 Ⅱ 及分泌状态对肝癌早期复发的影响:开腹手术与腹腔镜手术的比较
Cancer Med. 2023 Sep;12(17):17866-17877. doi: 10.1002/cam4.6422. Epub 2023 Aug 18.
5
Laparoscopic Hepatectomy versus Open Hepatectomy After Conversion Therapy Using Transarterial Chemoembolization or Hepatic Arterial Infusion Chemotherapy for Patients with Initially Unresectable Hepatocellular Carcinoma.对于初始不可切除的肝细胞癌患者,经动脉化疗栓塞或肝动脉灌注化疗转化治疗后腹腔镜肝切除术与开腹肝切除术的比较
J Hepatocell Carcinoma. 2023 Jul 21;10:1157-1167. doi: 10.2147/JHC.S417739. eCollection 2023.
6
Contrast-enhanced ultrasound guidance improves the therapeutic efficacy of radiofrequency ablation in liver cancer patients.超声造影引导可提高肝癌患者射频消融的治疗效果。
Am J Transl Res. 2023 Jun 15;15(6):3856-3863. eCollection 2023.
7
2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma.《2022年韩国肝脏癌协会-韩国国立癌症中心肝细胞癌管理实践指南》
J Liver Cancer. 2023 Mar;23(1):1-120. doi: 10.17998/jlc.2022.11.07. Epub 2022 Dec 9.
8
Surgical treatment for recurrent hepatocellular carcinoma: Current status and challenges.复发性肝细胞癌的外科治疗:现状与挑战
World J Gastrointest Surg. 2023 Apr 27;15(4):544-552. doi: 10.4240/wjgs.v15.i4.544.
9
Robotic versus laparoscopic liver resection for huge (≥10 cm) liver tumors: an international multicenter propensity-score matched cohort study of 799 cases.机器人手术与腹腔镜手术治疗巨大(≥10厘米)肝脏肿瘤:一项799例的国际多中心倾向评分匹配队列研究。
Hepatobiliary Surg Nutr. 2023 Apr 10;12(2):205-215. doi: 10.21037/hbsn-22-283. Epub 2023 Mar 17.
10
An integrated strategy for deciding open versus laparoscopic hepatectomy for resectable primary liver cancer.一种用于决定可切除原发性肝癌行开腹肝切除术或腹腔镜肝切除术的综合策略。
BMC Cancer. 2023 Feb 27;23(1):193. doi: 10.1186/s12885-023-10630-x.